Talecris Biotherapeutics sponsors immune deficiency e-newsletter

Talecris Biotherapeutics sponsors immune deficiency e-newsletter       

A grant from Talecris Biotherapeutics is sponsoring a new electronic newsletter from the Immune Deficiency Foundation. The free, monthly newsletter, the Primary Immune Tribune, aims to give patients, caregivers, and healthcare professionals new information about resources, activities, and programs. For example, in its inaugural issue this month, the Tribune provides information about family retreats that feature physicians who discuss treatments, prescription reimbursement, and life management. There is also information about a fund-raising program that will increase awareness about the importance of plasma donations. North Carolina-based Talecris makes liquid immune globulin intravenous therapy, which is used to treat primary immune deficiency.